[
  {
    "ts": null,
    "headline": "Why Dividend Aristocrats Like Walmart, ADP, and AbbVie Are Set to Outperform",
    "summary": "With Treasury yields coming down, more income-hungry investors could turn their attention to dividends, according to a new report by Wolfe Research.",
    "url": "https://finnhub.io/api/news?id=e2148213b9ca8706e1af4b22266279b2e5023e920d997a9bb775939a6acbb993",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733169120,
      "headline": "Why Dividend Aristocrats Like Walmart, ADP, and AbbVie Are Set to Outperform",
      "id": 131743313,
      "image": "",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "With Treasury yields coming down, more income-hungry investors could turn their attention to dividends, according to a new report by Wolfe Research.",
      "url": "https://finnhub.io/api/news?id=e2148213b9ca8706e1af4b22266279b2e5023e920d997a9bb775939a6acbb993"
    }
  },
  {
    "ts": null,
    "headline": "Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know",
    "summary": "Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
    "url": "https://finnhub.io/api/news?id=45fd00200fe0f5bb94bb7556fd8fd8a001ff2cc7812eb732c8e14a381a283724",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733164145,
      "headline": "Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know",
      "id": 131745673,
      "image": "https://media.zenfs.com/en/zacks.com/a41b81fe729c761f3f94f42ff348f70c",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=45fd00200fe0f5bb94bb7556fd8fd8a001ff2cc7812eb732c8e14a381a283724"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson : MENTOR™ MemoryGel™ Enhance Breast Implant Receives FDA Approval for Largest Size Breast Implants for Reconstruction",
    "summary": "Media contact: Investor contact: Tracy Menkowski ...",
    "url": "https://finnhub.io/api/news?id=fc89aa75b0a1ceee8843c1d78449421baa68f058ae4f5d343d5ed6dc37371b75",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733157673,
      "headline": "Johnson & Johnson : MENTOR™ MemoryGel™ Enhance Breast Implant Receives FDA Approval for Largest Size Breast Implants for Reconstruction",
      "id": 131742771,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Media contact: Investor contact: Tracy Menkowski ...",
      "url": "https://finnhub.io/api/news?id=fc89aa75b0a1ceee8843c1d78449421baa68f058ae4f5d343d5ed6dc37371b75"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson stock underperforms Monday when compared to competitors",
    "summary": "Johnson & Johnson stock underperforms Monday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=73ad7674df3f13cbd039d755d91b025c5186a63164653384b983580301f32288",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733157060,
      "headline": "Johnson & Johnson stock underperforms Monday when compared to competitors",
      "id": 131775379,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Johnson & Johnson stock underperforms Monday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=73ad7674df3f13cbd039d755d91b025c5186a63164653384b983580301f32288"
    }
  },
  {
    "ts": null,
    "headline": "Why Is Johnson & Johnson (JNJ) Among the Stocks Ray Dalio’s Bridgewater Is Crazy About?",
    "summary": "We recently compiled a list of the Billionaire Ray Dalio’s Bridgewater Is Crazy About These 15 Stocks. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other stocks Ray Dalio’s Bridgewater is crazy about. Ray Dalio, a seasoned global macro investor with over 50 years of […]",
    "url": "https://finnhub.io/api/news?id=eaa79684f7222849e702cd8589a5347295a46fb9355c0a4945d55aae66a102ab",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733142349,
      "headline": "Why Is Johnson & Johnson (JNJ) Among the Stocks Ray Dalio’s Bridgewater Is Crazy About?",
      "id": 131739204,
      "image": "https://s.yimg.com/ny/api/res/1.2/DBFyZ0OZ_JyFkP8R8eQoiQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/f9ccf3c88c7274582ef19e20143427c2",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the Billionaire Ray Dalio’s Bridgewater Is Crazy About These 15 Stocks. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other stocks Ray Dalio’s Bridgewater is crazy about. Ray Dalio, a seasoned global macro investor with over 50 years of […]",
      "url": "https://finnhub.io/api/news?id=eaa79684f7222849e702cd8589a5347295a46fb9355c0a4945d55aae66a102ab"
    }
  },
  {
    "ts": null,
    "headline": "J&J appoints Shawn Millerick to lead vision care unit in the Americas",
    "summary": "Millerick, who spent time at Abbott and Alcon, is responsible for defining strategy and driving growth at a J&J business that sells products including Acuvue contact lenses.",
    "url": "https://finnhub.io/api/news?id=93bfce78b47a7a737fdb4158b60d67eac3f9ae1d86b47e1e148d3c030905ad56",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733138640,
      "headline": "J&J appoints Shawn Millerick to lead vision care unit in the Americas",
      "id": 131745674,
      "image": "https://imgproxy.divecdn.com/g2migJBsOoo3N3DGze6O7AG5CchS6oGaX-e4PsqlXSc/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9TY3JlZW5zaG90XzIwMjQtMTEtMTlfYXRfMTEuNDIuNTBfQU0ucG5n.webp",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Millerick, who spent time at Abbott and Alcon, is responsible for defining strategy and driving growth at a J&J business that sells products including Acuvue contact lenses.",
      "url": "https://finnhub.io/api/news?id=93bfce78b47a7a737fdb4158b60d67eac3f9ae1d86b47e1e148d3c030905ad56"
    }
  },
  {
    "ts": null,
    "headline": "J&J: applies to the FDA for Tremfya in pediatrics",
    "summary": "Johnson & Johnson announces that it has submitted two supplemental Biologics License Applications to the FDA for approval of Tremfya in children aged 6 and over with moderate to severe plaque...",
    "url": "https://finnhub.io/api/news?id=fee877b0f248da46657912d4e2128f9f6d90b0337463a972f4d8b32050183d30",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733132114,
      "headline": "J&J: applies to the FDA for Tremfya in pediatrics",
      "id": 131738147,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Johnson & Johnson announces that it has submitted two supplemental Biologics License Applications to the FDA for approval of Tremfya in children aged 6 and over with moderate to severe plaque...",
      "url": "https://finnhub.io/api/news?id=fee877b0f248da46657912d4e2128f9f6d90b0337463a972f4d8b32050183d30"
    }
  },
  {
    "ts": null,
    "headline": "J&J: FDA green light for MemoryGel breast implants",
    "summary": "J&J announces that Mentor Worldwide LLC, the world's leading brand in breast aesthetics and a subsidiary of Johnson & Johnson MedTech, has received FDA approval for its MemoryGel Enhance breast...",
    "url": "https://finnhub.io/api/news?id=929bc3a25ab5935cc1d3959158287fb7b2c5cf670532e04ebc1e9d2f09cea33c",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733130976,
      "headline": "J&J: FDA green light for MemoryGel breast implants",
      "id": 131737978,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "J&J announces that Mentor Worldwide LLC, the world's leading brand in breast aesthetics and a subsidiary of Johnson & Johnson MedTech, has received FDA approval for its MemoryGel Enhance breast...",
      "url": "https://finnhub.io/api/news?id=929bc3a25ab5935cc1d3959158287fb7b2c5cf670532e04ebc1e9d2f09cea33c"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson seeks U.S. FDA approval for first pediatric indications for TREMFYA® (guselkumab)",
    "summary": "Applications filed for TREMFYA® to treat children with moderate to severe plaque psoriasis and active juvenile psoriatic arthritis  SPRING HOUSE, Pa., Dec. 2, 2024 /PRNewswire/ -- Johnson & Johnson...",
    "url": "https://finnhub.io/api/news?id=2ce3eef3187f55efa8cdd971c70937a8a57812f182f59b92cfcdaafbcf5fae8f",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733126470,
      "headline": "Johnson & Johnson seeks U.S. FDA approval for first pediatric indications for TREMFYA® (guselkumab)",
      "id": 131737262,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Applications filed for TREMFYA® to treat children with moderate to severe plaque psoriasis and active juvenile psoriatic arthritis  SPRING HOUSE, Pa., Dec. 2, 2024 /PRNewswire/ -- Johnson & Johnson...",
      "url": "https://finnhub.io/api/news?id=2ce3eef3187f55efa8cdd971c70937a8a57812f182f59b92cfcdaafbcf5fae8f"
    }
  },
  {
    "ts": null,
    "headline": "Tracking Ray Dalio's Bridgewater Associates 13F Portfolio - Q3 2024 Update",
    "summary": "Bridgewater Associates' 13F portfolio decreased to ~$17.66B. Read more to see the portfolio's Q3, 2024 update.",
    "url": "https://finnhub.io/api/news?id=05a13c4ff9c275f61946095101d3ec8a2bf74842725f5122607d8596b0d137d2",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733111195,
      "headline": "Tracking Ray Dalio's Bridgewater Associates 13F Portfolio - Q3 2024 Update",
      "id": 131735363,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1333504671/image_1333504671.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Bridgewater Associates' 13F portfolio decreased to ~$17.66B. Read more to see the portfolio's Q3, 2024 update.",
      "url": "https://finnhub.io/api/news?id=05a13c4ff9c275f61946095101d3ec8a2bf74842725f5122607d8596b0d137d2"
    }
  }
]